History | Bimekizumab for treating axial spondyloarthritis | Guidance | NICE

History

Expected publication

Equality Impact Assessment (Guidance development) (PDF 145 KB)

Published:

07 September 2023
Register of interests (PDF 126 KB)

Published:

01 December 2023

Final draft guidance

Final draft guidance
Final draft guidance (PDF 167 KB)

Published:

07 September 2023
Committee papers (PDF 8.67 MB)

Published:

07 September 2023

Invitation to participate

Final scope (PDF 247 KB)

Published:

04 May 2023
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 294 KB)

Published:

04 May 2023
Final stakeholder list (PDF 166 KB)

Published:

04 May 2023
Equality impact assessment (Scoping) (PDF 125 KB)

Published:

04 May 2023